Tag Archives: FDA
Aradigm Corporation [NASDAQ: ARDM]
Federman & Sherwood Announces the Filing of a Securities Class Action Lawsuit against Aradigm Corporation Oklahoma City, OK (January 14, 2018) – On January 11, 2018, a securities class action lawsuit was filed in the United States District Court for the Northern District of California against Aradigm Corporation (NASDAQ: ARDM). The complaint alleges violations… Read More »
Antares Pharma, Inc.
Federman & Sherwood Announces the Filing of a Securities Class Action Lawsuit against Antares Pharma, Inc. Oklahoma City, OK (October 25, 2017) – On October 23, 2017, a securities class action lawsuit was filed in the United States District Court for the District of New Jersey against Antares Pharma, Inc. (NASDAQ: ATRS). The complaint… Read More »